1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
IPMN of the pancreas–does histological subtyping allow for improved stratification and follow-up?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Acute pancreatitis–can evidence-based guidelines be transferred to an optimized comprehensive treatment program?
(
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
Expression of fibroblast activation protein and the clinicopathological relevance in distal cholangiocarcinoma
(
- Contribution to journal › Article
-
Mark
The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data
(
- Contribution to journal › Article
-
Mark
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker
(
- Contribution to journal › Article
-
Mark
YAP1 is an independent prognostic marker in pancreatic cancer and associated with extracellular matrix remodeling
(
- Contribution to journal › Article
- 2019
-
Mark
The role of PEDF in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
The hippo signaling pathway in pancreatic cancer
(
- Contribution to journal › Scientific review
-
Mark
Quantitative proteomics identifies brain acid soluble protein 1 (BASP1) as a prognostic biomarker candidate in pancreatic cancer tissue
(
- Contribution to journal › Article
-
Mark
Galectin 4 is a biomarker for early recurrence and death after surgical resection for pancreatic ductal adenocarcinoma
(
- Contribution to journal › Article